성병 진단 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The STD Diagnostics Market size is expected to reach USD 30.59 Billion in 2034 from USD 16.28 Billion (2025) growing at a CAGR of 7.26% during 2026-2034.

The global STD diagnostics market is expanding rapidly as awareness regarding sexually transmitted diseases (STDs) continues to increase worldwide. Early detection and diagnosis play a critical role in controlling the spread of infections such as HIV, chlamydia, gonorrhea, and syphilis. Governments and healthcare organizations are promoting routine screening programs and public health campaigns to encourage testing. This growing awareness, along with the rising prevalence of STDs, is significantly driving the demand for advanced diagnostic solutions.

Technological advancements in diagnostic tools are also supporting market growth. Modern testing methods, including molecular diagnostics, rapid testing kits, and point-of-care testing solutions, provide faster and more accurate results. These innovations help healthcare providers diagnose infections quickly and initiate appropriate treatment. Additionally, increased investment in healthcare infrastructure and improved access to diagnostic facilities in developing regions are further boosting market expansion.

In the coming years, the STD diagnostics market is expected to witness strong growth due to the increasing focus on preventive healthcare and early disease detection. The development of portable diagnostic devices and self-testing kits will make STD testing more convenient and accessible for individuals. As healthcare systems continue to emphasize early diagnosis and effective disease management, the demand for advanced STD diagnostic solutions will continue to rise globally.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Instruments And Services
• Consumables
• Software

By Application

• CT/NG Testing
• Syphilis Testing
• Gonorrhea Testing
• HSV Testing
• HPV Testing
• HIV Testing
• Ureaplasma & Mycoplasma Testing
• Trichomonas
• Vzv Testing
• Others

By Technology

• Immunoassay
• Molecular Diagnostics
• Other

By Location of Testing

• Laboratory Testing
• Point of Care Testing

COMPANIES PROFILED

• BD, F HoffmannLa Roche Ltd, Hologic Inc, Abbott, Cepheid Danaher, Qiagen, OraSure Technologies Inc, BioRad Laboratories Inc, bioMrieux SA, Thermo Fisher Scientific Inc, Seegene Inc, DiaSorin SpA
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL STD DIAGNOSTICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Instruments And Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL STD DIAGNOSTICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. CT/NG Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Syphilis Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Gonorrhea Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. HSV Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. HPV Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. HIV Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Ureaplasma & Mycoplasma Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Trichomonas Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.10. Vzv Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.11. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL STD DIAGNOSTICS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Technology
• 6.2. Immunoassay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Molecular Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL STD DIAGNOSTICS MARKET: BY LOCATION OF TESTING 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Location Of Testing
• 7.2. Laboratory Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Point of Care Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL STD DIAGNOSTICS MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Application
  • 8.2.3 By Technology
  • 8.2.4 By Location Of Testing
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Application
  • 8.3.3 By Technology
  • 8.3.4 By Location Of Testing
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Application
  • 8.4.3 By Technology
  • 8.4.4 By Location Of Testing
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Application
  • 8.5.3 By Technology
  • 8.5.4 By Location Of Testing
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Application
  • 8.6.3 By Technology
  • 8.6.4 By Location Of Testing
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL STD DIAGNOSTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 BD
  • 10.2.2 F. Hoffmann-La Roche Ltd
  • 10.2.3 Hologic Inc
  • 10.2.4 Abbott
  • 10.2.5 Cepheid (Danaher)
  • 10.2.6 Qiagen
  • 10.2.7 OraSure Technologies Inc
  • 10.2.8 Bio-Rad Laboratories Inc
  • 10.2.9 BioMerieux SA
  • 10.2.10 Thermo Fisher Scientific Inc
  • 10.2.11 Seegene Inc
  • 10.2.12 DiaSorin S.p.A